fbpx

Health Care

BioZone merges with Washington antiviral company

The deal is expected to close at the end of 2013. The transaction is structured as a reverse merger with the surviving corporation, Cocrystal Pharma Inc, headquartered in Bothell, Washington, according to a news release. BioZone Pharmaceuticals manufactures over-the-counter drugs and cosmetic and beauty products on behalf of third parties. The profitable company reports about ...

Read More »

Bayer wins approval for expanded use of cancer drug Nexavar

The Food and Drug Administration last week approved the new indication for Nexavar, which is already approved to treat liver and kidney cancer. The partners submitted the application this summer.Nexavar, co-marketed with Bayer and Calif.-based Onyx Pharmaceuticals Inc., targets a late-stage form of the disease — called advanced differentiated thyroid cancer — that does not ...

Read More »

Merck increases dividend

According to the announcement, its board has increased the company’s quarterly dividend to 44 cents per outstanding share of the company’s common stock, up one cent from 43 cents per outstanding share paid last quarter. Payment will be made on January 8, 2014, to stockholders of record at the close of business on December 16, ...

Read More »

NFIB: Latest ACA plan won’t sell in New Jersey

“I don’t think you can put the toothpaste back in the tube,” said Jack Mozloom, spokesman for the New Jersey chapter of the National Federation of Independent Businesses. “The bad news regarding this program has just been relentless for the last month and a half. What’s alarming is how much we didn’t know about the ...

Read More »

Celsion announces up to $20M strategic loan facility

According to the announcement, Celsion drew the first tranche of $5 million upon closing of the loan agreement Monday. Approximately $4 million of the proceeds were used to repay the outstanding obligations under the Company’s loan agreement with Oxford Finance LLC and Horizon Technology Finance Corporation. The company anticipates it would use any additional funding ...

Read More »

BioReference The accidental laboratory is growing fast

Grodman’s original plan was occupational medicine — serving firefighters, nursing home workers and other professions that require health verifications — out of a mobile van. Only problem: Grodman soon discovered there wasn’t much money there. He went shopping for a laboratory instead and in 1986 acquired Bio-Med Clinical, a New Jersey operation with New York ...

Read More »

PriorityOne Group is there when companies make IT upgrades a priority

One big reason? Obamacare. The Affordable Care Act’s goal of lowering health care spending is prompting small physicians’ practices to consider mergers to control their overhead expenses. And when practices join forces, they need firms such as the Rutherford-based PriorityOne to deliver the IT solutions that get all the doctors behaving like a single business ...

Read More »

Obamacare is both good and bad for lab business

Grodman said ongoing confusion over the ACA mandates, worsened by the bumpy rollout of online exchanges and controversy over cancelled and reinstated policies, could make it harder on laboratories and other providers when dealing with insurance carriers. “One of the unintended consequences is that payers will take umbrage from this and try to put pressure ...

Read More »

Branching out

In an era when people actually go into physical banks far less often than ever before — quick, find a teenager and ask them if they’ve ever actually been inside a bank — you can understand why consumers may be hoping instead for the latest trendy store or restaurant. But if you ask a banker, ...

Read More »

Incentives are great, but not a cure-all to N.J.’s woes

In any case, the ink on the Economic Opportunity Act has yet to dry and we’re already discussing how we need to fix it, sort of like Jacksonville Jaguars fans after the first snap of the season. This isn’t exactly new — the massive Urban Transit Hub subsidy went through more rewrites than “Ulysses” — ...

Read More »

Growth, fueled by outpatient advances, drives Vein and Vascular Institute expansion

Dietzek made the move to accommodate the more than four-fold growth of his practice over the past decade, reflecting the development of new, less invasive outpatient procedures for treating varicose veins and other vein diseases.Vein disease “tends to be a chronic, nagging problem,” for patients, Dietzek said, but if left untreated the problem can progress ...

Read More »